Efficacy and safety of bucillamine, a d-penicillamine analogue, in patients with active rheumatoid arthritis
Tóm tắt
Japanese rheumatologists consider bucillamine (Buc) to be a useful disease-modifying antirheumatic drug (DMARD) and often give Buc to patients with rheumatoid arthritis (RA) prior to administering methotrexate (MTX). However, no large studies on the efficacy and safety of Buc in RA patients have been published in English to date. We therefore investigated the clinical course of RA patients treated with Buc and compared the results with those for patients treated with MTX to evaluate and confirm the place of Buc in therapeutic strategies for RA in Japan. Our results suggested that Buc should be given to patients with moderately active RA either before or after the administration of MTX because its efficacy can be judged within 3 months and because serious adverse events are rare. Issues like the ability of Buc to prevent joint destruction and its efficacy and safety when combined with agents like etanercept require future study.
Tài liệu tham khảo
InstitutionalAuthorNameAmerican College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) ArticleTitleGuidelines for the management of rheumatoid arthritis: 2002 Update Arthritis Rheum 6 IssueID2 328–46 Occurrence Handle10.1002/art.10148
MC Hochberg (1981) ArticleTitleAdult and juvenile rheumatoid arthritis: current epidemiologic concepts Epidemiol Rev 3 27–44 Occurrence Handle1:STN:280:DyaL38%2Fnt12qtQ%3D%3D Occurrence Handle7030763
JM Kremer JK Lee (1986) ArticleTitleThe safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis Arthritis Rheum 29 822–31 Occurrence Handle10.1002/art.1780290702 Occurrence Handle1:STN:280:DyaL283psF2htg%3D%3D Occurrence Handle3741499
H Kamdeda K Amano N Sekiguchi H Takei H Ogawa H Nagasawa et al. (2004) ArticleTitleFactors predicting the response to lowdose methotrexate therapy in patients with rheumatoid arthritis: a better response in male patients Mod Rheumatol 14 442–6 Occurrence Handle10.1007/s10165-004-0340-3
S Ohno M Misumi H Ideguchi T Tsuji A Ueda E Hagiwara et al. (2002) ArticleTitleHow Japanese Clinicians Treat Rheumatoid Arthritis (RA): a survey at the 44th Annual Meeting of Japan Rheumatism Association in 2000 Ryumachi 42 IssueID1 40–52 Occurrence Handle11925906
S Kashiwazaki Y Shiokawa (1987) ArticleTitleBucillamine: a new immunomodulator Int J Immunother 3 IssueID1 1–6
Y Ichikawa T Saito H Yamanaka M Akizuki H Kondo S Kobayashi et al. (2005) ArticleTitleTherapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study Mod Rheumatol 15 323–8 10.1007/s10165-005-0420-z Occurrence Handle10.1007/s10165-005-0420-z Occurrence Handle1:CAS:528:DC%2BD2MXhtFWmtLbF Occurrence Handle17029087
H Matsushima N Takayanagi T Sakamoto M Motegi M Ubukata T Yanagisawa et al. (2001) ArticleTitleA case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine Nihon Kokyuki Gakkai Zasshi 39 IssueID1 55–9 Occurrence Handle1:STN:280:DC%2BD3MzpsVOhtw%3D%3D Occurrence Handle11296388
HA Kim YW Song (1997) ArticleTitleA comparison between bucillamine and d-penicillamine in the treatment of rheumatoid arthritis Rheumatol Int 17 IssueID1 5–9 10.1007/PL00006849 Occurrence Handle10.1007/PL00006849 Occurrence Handle1:CAS:528:DyaK2sXktV2qsLw%3D Occurrence Handle9194208
HE Howard-Lock CJ Lock A Mewa WF Kean (1986) ArticleTitle d-Penicillamine: chemistry and clinical use in rheumatic disease (Review) Semin Arthritis Rheum 15 IssueID4 261–81 10.1016/0049-0172(86)90022-3 Occurrence Handle10.1016/0049-0172(86)90022-3 Occurrence Handle1:STN:280:DyaL283jsFCkug%3D%3D Occurrence Handle2940684
HB Stein A Chalmers ML Schroeder A Dillon (1984) ArticleTitleSelected adverse reactions of d-penicillamine Clin Invest Med 7 IssueID1 73–6 Occurrence Handle1:STN:280:DyaL2c3gs1arsw%3D%3D Occurrence Handle6723128
RJ McKendry P Dale (1993) ArticleTitleAdverse effects of low dose methotrexate therapy in rheumatoid arthritis J Rheumatol 20 IssueID11 1850–6 Occurrence Handle1:STN:280:DyaK2c7ktFOrtg%3D%3D Occurrence Handle8308769
J Borras-Blasco A Navarro-Ruiz J Matarredona P Devesa A Montesinos-Ros M Gonzalez-Delgado (2003) ArticleTitlePhoto-induced Stevens-Johnson syndrome due to sulfasalazine therapy Ann Pharmacother 37 IssueID9 1241–3 Occurrence Handle10.1345/aph.1C271 Occurrence Handle12921507
Y Kamata H Nara T Kamimura K Haneda M Iwamoto J Masuyama et al. (2004) ArticleTitleRheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction Intern Med 43 IssueID12 1201–4 10.2169/internalmedicine.43.1201 Occurrence Handle10.2169/internalmedicine.43.1201 Occurrence Handle15645660